Research Article
Labelling of Y- and Lu-DOTA-Bioconjugates for Targeted Radionuclide Therapy: A Comparison among Manual, Semiautomated, and Fully Automated Synthesis
Figure 3
Images of the ML Eazy device (a), a disposable cassette (b), and disposable cassettes assembled onto the system (c). Delivery vial (90Y and 177Lu-chloride solutions) (1), reagent vial (precursor and buffer solution) (2), reactor vial (3), waste vial (4), 0.9% NaCl solution vial (5), and product vial (6).
(a) |
(b) |
(c) |